Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Evaluation of plasma nucleosome concentrations and the effect of pre-analytical variables in healthy cats

Monday, May 19, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The article discusses a study on plasma nucleosome concentrations in healthy cats, published in BMC Veterinary Research. This research is anticipated to facilitate a $5 million milestone payment for Volition following its publication. The study contributes to the development of the Nu.Q® Vet Cancer Test, marking a significant advancement in veterinary diagnostics.
Price reaction · baseline $8.8 (2025-05-19T13:41:00.000Z) · hit during market hours · clean, no other VNRX news in the window
day 0 close · peak
-4.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Study published in a peer-reviewed journal enhances credibility.
  • Expected to unlock a $5 million milestone payment.
  • First automated cancer test for cats shows innovation.

Full Press Release Details

Paper titled: Evaluation of plasma nucleosome concentrations and the effect of pre-analytical variables in healthy cats
Published in: BMC Veterinary Research
Authors: Emily Westerback, Heather Wilson-Robles, M’hammed Bougoussa, Stephanie Istvan, Samuel Stewart, Emma Warry & Justin Heinz

Related Articles

• Press Releases Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment
• Press Releases Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment

Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the focus of the study?

The study evaluates plasma nucleosome concentrations in healthy cats.

Where was the study published?

The study was published in BMC Veterinary Research.

What milestone payment is expected from this study?

The publication is expected to unlock a $5 million milestone payment.

What innovation does this study contribute to?

It contributes to the development of the Nu.Q® Vet Cancer Test for cats.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare plasma nucleosome Nu.Q Vet Cancer Test veterinary research cat cancer testing
Last updated: May 19, 2025

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk